Bristol-Myers Squibb completes acquisition of Inhibitex, Inc.
13 February 2012 | By Bristol-Myers Squibb Company
Completion of the tender offer by Bristol-Myers for all of the outstanding shares of common stock of Inhibitex, Inc...
List view / Grid view
13 February 2012 | By Bristol-Myers Squibb Company
Completion of the tender offer by Bristol-Myers for all of the outstanding shares of common stock of Inhibitex, Inc...
13 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is commencing a cash tender offer to purchase all outstanding shares of common stock of Inhibitex...
7 January 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb to acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger...